Where Quality of Life Intersects With Making Medical Decisions
As part of our coverage of the 2019 American Society of Hematology (ASH) Annual Meeting & Exposition, a panel of MPN and myeloma experts discuss progress in genetic research, and a critical component to a patient’s treatment journey; quality of life.